APA (7th ed.) Citation

Gao, F., Wu, X., Wu, J., Li, Y., Miao, Z., & Song, L. RETRACTED: De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report. SAGE Publishing.

Chicago Style (17th ed.) Citation

Gao, Fei, Xiuyan Wu, Jie Wu, Yanlin Li, Zhibo Miao, and Lei Song. RETRACTED: De Novo HER2 S310Y Mutation Associates with Poor Response to EGFR Tyrosine Kinase Inhibitor in Activating EGFR-mutant NSCLC Patient: A Case Report. SAGE Publishing.

MLA (9th ed.) Citation

Gao, Fei, et al. RETRACTED: De Novo HER2 S310Y Mutation Associates with Poor Response to EGFR Tyrosine Kinase Inhibitor in Activating EGFR-mutant NSCLC Patient: A Case Report. SAGE Publishing.